Clinical Trials Logo

Computer Vision Syndrome clinical trials

View clinical trials related to Computer Vision Syndrome.

Filter by:

NCT ID: NCT04668118 Recruiting - Dry Eye Syndromes Clinical Trials

The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye

Start date: February 1, 2021
Phase: Phase 4
Study type: Interventional

This study aims to evaluate the efficacy and safety of 3% Diquafosol Ophthalmic Solution for visual display terminal (VDT)-associated dry eye and to investigate the mechanism of treatment.

NCT ID: NCT04637516 Completed - Dry Eye Syndromes Clinical Trials

Evaluation of an Updated Version of the Program "BlinkBlink" for Alleviation of Dry Eye Symptoms Induced by Computer Work

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

The program "BlinkBlink" was developed to alleviate dry eye symptoms during prolonged computer work. This study aimed to show subjective and objective improvement of dry eye problems in a sample size of office workers

NCT ID: NCT04405648 Completed - Clinical trials for Computer Vision Syndrome

Computer Vision Syndrome Prevalence Among University Students

Start date: May 28, 2020
Phase:
Study type: Observational

CVS-F3 questionnaire will be used as an instrument to survey CVS prevalence and severity among medical students

NCT ID: NCT04398212 Completed - Clinical trials for Computer Vision Syndrome

Computer Vision Syndrome Visual Sequelae

Start date: May 21, 2018
Phase: N/A
Study type: Interventional

the university students will respond to CVS-F3 survey form and then they will be subjected to complete ophthalmic examination and investigations

NCT ID: NCT03831919 Completed - Clinical trials for Computer Vision Syndrome

Trial of Hoya SYNC III Design Lenses

SYNCIII
Start date: January 7, 2019
Phase: N/A
Study type: Interventional

Many people using computers or digital devices (e.g., smartphones or tablets) experience eyestrain and this has been called Computer Vision Syndrome (CVS) or Digital Eye Strain. Spectacle lens manufacturers have designed products to alleviate the symptoms of CVS. One such product, designed by Hoya (SYNC III), aims to do this by providing accommodative support. The present study is a parallel group double-masked RCT of people with CVS. One group will receive Hoya SYNC III lenses and the other (control) group single vision (SV) lenses. The main aims are to evaluate whether: 1. binocular vision and accommodative functions at baseline can predict participants who benefit from SYNC III design lenses; 2. the wearing of SYNC III design lenses is associated with any changes in binocular and accommodative functions at 6 months of follow-up; 3. the wearing of lenses with accommodative support reduce the symptoms of computer vision syndrome at 3 and 6 months of follow-up. Participants will be examined three times: at baseline and three and six months after receiving their lenses. The group who receive control lenses will be provided with SYNC III lenses at the end of the six month trial for a brief one week follow-up evaluation.